title: [Correction of central nervous system energy processes in children with the minimal cerebral dysfunction].
abstract: Clinical-neurophysiological investigation of the efficiency of complex metabolic neuroprotector Cytoflavin in monotherapy was performed in 64 children of 4-8 years old with the minimal cerebral dysfunction. During the treatment other preparations were not used. Neurologic status, neurophysiological inspection, neuropsychophysiological and speech testing were performed before and after the course of treatment. Efficiency of Cytoflavin was established in children with the minimal cerebral dysfunction of preschool and early school age. By increasing a cerebral blood flow, improving parameters EEG and decreasing intracranial pressure, the drug had positive influence on the psycho-emotional and cognitive spheres, decreased asthenia syndrome, improving social adaptation of the children. Side-effects of Cytoflavin administration were not observed.
authors.forename: S Iu
authors.initials: SIu
authors.lastname: Lavrik
authors.forename: S V
authors.initials: SV
authors.lastname: Domitrak
authors.forename: V V
authors.initials: VV
authors.lastname: Shprakh
mesh_terms: D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology; D001921:Brain / Q000098:blood supply / Q000187:drug effects* / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations; D004734:Energy Metabolism / Q000187:drug effects*; D005260:Female; D005486:Flavin Mononucleotide / Q000008:administration & dosage*; D006801:Humans; D007290:Inosine Diphosphate / Q000008:administration & dosage*; D009536:Niacinamide / Q000008:administration & dosage*; D012039:Regional Blood Flow; D013386:Succinates / Q000008:administration & dosage*
chemical_list: D004338:Drug Combinations; D013386:Succinates; C507879:cytoflavin; D009536:Niacinamide; D005486:Flavin Mononucleotide; D007290:Inosine Diphosphate